China approves IPO of Zhejiang-based pharmaceutical company

BEIJING, Sept. 22 (Xinhua) — China’s top securities regulator has approved an IPO application, which is expected to raise up to 600 million yuan (about 87.5 million U.S. dollars) in the A-share marke…
( read original story …)



Related Post